Welcome to LookChem.com Sign In|Join Free

CAS

  • or

789-61-7

Post Buying Request

789-61-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

789-61-7 Usage

Uses

Guanosine (G837900) derivative with cancer chemotherapeutic properties. It is involved in the inhibition of human RNase H-mediated RNA cleavage from DNA-RNA duplexes via incorporation into DNA.

Biological Activity

6-thio-dg is a nucleoside analogue [1], is a telomerase-mediated telomere disrupting compound [2]. it is an anti-cancer inhibitor [1]. cancer cells were very sensitive to 6-thio-dg with observed ic50 values ranging from 0.7-2.9 μm, depending on cell types [3].telomeres are found at the end of eukaryotic linear chromosomes. they are essential for genomic stability and chromosome maintenance [3].in hct116 human colon cancer cell line, treatment with 6-thio-dg made progressive telomere shortening independent of telomerase activity inhibition and induced telomere dysfunction. grn163l is a telomerase inhibitor. in hct116 cells, treatment with grn163l and 6-thio-dg together increased telomere shortening. within 1 week, 6-thio-dg killed most of hct116 cells and altered cellular morphology. normal bj fibroblast cells are telomerase silent. after 1 week, treatment with 6-thio-dg showed no effect on cell morphology. after long-term treatment with 6-thio-dg, no effect on telomere shortening was found [1].in murine mode with xenograft derived from a549 lung cancer cell line, as compared to controls, intraperitoneal injection with 2 mg/kg of 6-thio-dg every other day completely prevented progressive tumor growth. ki67 is a biomarker correlating with proliferation levels. compared to controls, 6-thio-dg decreased ki67 staining. treatment with 6-thio-dg through local injection resulted in even more dramatic decrease in the tumor growth rate compared to untreated controls [3].

references

[1]. mender i, gryaznov s, dikmen zg, et al. abstract lb-125: a novel telomerase inhibitor. cancer research, 2013, 73(8 supplement): lb-125-lb-125.[2]. mender i, gryaznov s, shay jw. a novel telomerase substrate precursor rapidly induces telomere dysfunction in telomerase positive cancer cells but not telomerase silent normal cells. oncoscience, 2015, 2(8): 693.[3]. mender i, gryaznov s, dikmen zg, et al. induction of telomere dysfunction mediated by the telomerase substrate precursor 6-thio-2-deoxyguanosine. cancer discovery, 2015, 5(1): 82-95.

Check Digit Verification of cas no

The CAS Registry Mumber 789-61-7 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 7,8 and 9 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 789-61:
(5*7)+(4*8)+(3*9)+(2*6)+(1*1)=107
107 % 10 = 7
So 789-61-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H13N5O3S/c11-10-13-8-7(9(19)14-10)12-3-15(8)6-1-4(17)5(2-16)18-6/h3-6,16-17H,1-2H2,(H3,11,13,14,19)

789-61-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (SML1296)  6-Thio-2′-Deoxyguanosine  ≥97% (HPLC)

  • 789-61-7

  • SML1296-5MG

  • 983.97CNY

  • Detail
  • Sigma

  • (SML1296)  6-Thio-2′-Deoxyguanosine  ≥97% (HPLC)

  • 789-61-7

  • SML1296-25MG

  • 3,970.98CNY

  • Detail

789-61-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-THIO-2'-DEOXYGUANOSINE

1.2 Other means of identification

Product number -
Other names 2'-deoxyribo-6-thioguanosine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:789-61-7 SDS

789-61-7Synthetic route

Isobutyric acid (2R,3S,5R)-5-(2-isobutyrylamino-6-thioxo-1,6-dihydro-purin-9-yl)-2-isobutyryloxymethyl-tetrahydro-furan-3-yl ester
136112-93-1

Isobutyric acid (2R,3S,5R)-5-(2-isobutyrylamino-6-thioxo-1,6-dihydro-purin-9-yl)-2-isobutyryloxymethyl-tetrahydro-furan-3-yl ester

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine
789-61-7

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine

Conditions
ConditionsYield
With sodium hydroxide In ethanol100%
2'-Deoxyguanosine
961-07-9

2'-Deoxyguanosine

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine
789-61-7

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine

Conditions
ConditionsYield
With sodium hydrogensulfide; trifluoroacetic anhydride In pyridine; N,N-dimethyl-formamide65%
With pyridine; sodium hydrogensulfide; trifluoroacetic anhydride 1) 40 min, ice-bath, 2) DMF, 24 h; Yield given. Multistep reaction;
2-Amino-6-chloro-9-(2-deoxy-3,5-di-O-p-toluoyl-β-D-erythro-pentofuranosyl)purine
35095-93-3

2-Amino-6-chloro-9-(2-deoxy-3,5-di-O-p-toluoyl-β-D-erythro-pentofuranosyl)purine

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine
789-61-7

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine

Conditions
ConditionsYield
With hydrogen sulfide; sodium methylate 1) anhydr. MeOH, reflux, 2 h; 2) MeOH, reflux, 1 h; Yield given. Multistep reaction;
2-deoxy-3,5-di-O-p-toluoyl-α-D-erythro-pentofuranosyl chloride
4330-21-6

2-deoxy-3,5-di-O-p-toluoyl-α-D-erythro-pentofuranosyl chloride

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine
789-61-7

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 51 percent / 1) sodium hydride (60percent in oil) / 1) acetonitrile, RT, 30 min; 2) acetonitrile, 20 h
2: 1) H2S/1M sodium methoxide; 2) 1M sodium methoxide / 1) anhydr. MeOH, reflux, 2 h; 2) MeOH, reflux, 1 h
View Scheme
2-Amino-6-chloropurin
10310-21-1

2-Amino-6-chloropurin

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine
789-61-7

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 51 percent / 1) sodium hydride (60percent in oil) / 1) acetonitrile, RT, 30 min; 2) acetonitrile, 20 h
2: 1) H2S/1M sodium methoxide; 2) 1M sodium methoxide / 1) anhydr. MeOH, reflux, 2 h; 2) MeOH, reflux, 1 h
View Scheme
2'-deoxy-N2-isobutyrylguanosine 3',5'-diisobutyrate
82921-42-4

2'-deoxy-N2-isobutyrylguanosine 3',5'-diisobutyrate

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine
789-61-7

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1. triethylamine, dimethylaminopyridine, mesitylenesulphonyl chloride, 2a. N-methyl pyrrolidine, 2b. thiolacetic acid / 1. CH2Cl2, RT, 2a. ice bath, 2b. 30 min
2: 100 percent / 2 M NaOH / ethanol
View Scheme
2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine
789-61-7

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)purine-6-sulfenamide
124416-63-3

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)purine-6-sulfenamide

Conditions
ConditionsYield
With potassium hydroxide; sodium hydroxide; sodium hypochlorite In water 0 deg C to RT;86%
2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine
789-61-7

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine

2-amino-9-(β-D-2'-deoxyribofuranosyl)-purine
3616-24-8

2-amino-9-(β-D-2'-deoxyribofuranosyl)-purine

Conditions
ConditionsYield
nickel In ethanol; water desulfuration; Heating;77%
With nickel75%
With nickel In water at 50℃; for 13h;73%
2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine
789-61-7

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine

triethylamine
121-44-8

triethylamine

2'-deoxy-6-thioguanosine-5'-triphosphate triethylammonium salt

2'-deoxy-6-thioguanosine-5'-triphosphate triethylammonium salt

Conditions
ConditionsYield
Stage #1: 2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine With phosphorous acid trimethyl ester; trichlorophosphate at 0℃; for 3h; phosphorylation;
Stage #2: triethylamine With tributyl-amine; bis(tri-n-butylammonium) pyrophosphate In N,N-dimethyl-formamide pH=7.0; phosphorylation;
38%
2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine
789-61-7

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine

cobalt(II) nitrate hexahydrate

cobalt(II) nitrate hexahydrate

[Co(2'-deoxy-6-thioguanine)3](NO3)2 dihydrate

[Co(2'-deoxy-6-thioguanine)3](NO3)2 dihydrate

Conditions
ConditionsYield
In methanol at 60℃; for 24h;31%
2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine
789-61-7

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine

methyl iodide
74-88-4

methyl iodide

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-(methylthio)purine
37113-42-1

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-(methylthio)purine

Conditions
ConditionsYield
In ammonium hydroxide other conditions: phosphate aq. solution, pH 8.5;
With ammonium hydroxide for 0.666667h; Ambient temperature;90 mg
With ammonium hydroxide for 1.5h;
2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine
789-61-7

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine

A

thioguanine
154-42-7

thioguanine

B

2-deoxy–α-D-ribose 1-phosphate
17039-17-7

2-deoxy–α-D-ribose 1-phosphate

Conditions
ConditionsYield
With E. coli purine nucleoside phosphorylase Enzyme kinetics; Substitution;
2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine
789-61-7

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine

9-(2-deoxy-β-D-ribofuranosyl)purine-2-thione

9-(2-deoxy-β-D-ribofuranosyl)purine-2-thione

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 77 percent / Raney nickel / H2O; ethanol / Heating
2: 80 percent / pyridine / 2 h
3: 35 percent / SbCl3; tert-butyl nitrite / CH2Cl2 / 4 h / -5 °C
4: pyridine / 72 h / 75 °C
5: 40 percent / NH3; 2-mercaptoethanol / methanol / 24 h / 20 °C
View Scheme
2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine
789-61-7

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine

2-chloro-9-(2-deoxy-3,5-diisobutyryl-β-D-ribofuranosyl)purine
273721-25-8

2-chloro-9-(2-deoxy-3,5-diisobutyryl-β-D-ribofuranosyl)purine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 77 percent / Raney nickel / H2O; ethanol / Heating
2: 80 percent / pyridine / 2 h
3: 35 percent / SbCl3; tert-butyl nitrite / CH2Cl2 / 4 h / -5 °C
View Scheme
2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine
789-61-7

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine

(R,S)-2-amino-9-(2-deoxy-β-D-erythro-pentafuranosyl)purine-6-sulfinamide
124416-58-6

(R,S)-2-amino-9-(2-deoxy-β-D-erythro-pentafuranosyl)purine-6-sulfinamide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 86 percent / NaOCl, NaOH, 2N KOH / H2O / 0 deg C to RT
2: 69 percent / MCPBA / CH2Cl2; ethanol / 1.5 h / 0 deg C to RT
View Scheme
2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine
789-61-7

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)purine-6-sulfonamide
124416-64-4

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)purine-6-sulfonamide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 86 percent / NaOCl, NaOH, 2N KOH / H2O / 0 deg C to RT
2: 50 percent / MCPBA / ethanol / Ambient temperature
View Scheme
2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine
789-61-7

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine

chloroamine
12190-75-9

chloroamine

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)purine-6-sulfenamide
124416-63-3

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)purine-6-sulfenamide

Conditions
ConditionsYield
With sodium hypochlorite In potassium hydroxide; ammonium hydroxide; ethanol2.5 g (84%)
2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine
789-61-7

2-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercapto-9H-purine

trifluoroethylamine
753-90-2

trifluoroethylamine

2-amino-N6-(2,2,2-trifluoroethyl)-2'-deoxyadenosine

2-amino-N6-(2,2,2-trifluoroethyl)-2'-deoxyadenosine

Conditions
ConditionsYield
With sodium periodate at 50℃; for 1h; Darkness;

789-61-7Relevant articles and documents

6-O-substituted guanosine derivatives

-

, (2008/06/13)

The following species of N6-activated guanosine derivatives are disclosed: 2-N-trifluoroacetamido-6-(4-nitrophenoxy)-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine 2-N-trifluoroacetamido-6-pentafluorophenoxy-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine 6-dimethylpyridinium-9-(2-deoxy-beta-D-erythropentofuranosyl)purine These guanosine compounds are useful as precursors in the synthesis of a wide variety of antiviral and anticancer nucleosides such as 2-amino-2-deoxyadenosine or 6-thio-deoxyguanosine. Also disclosed are oligonucleotides containing the above nucleosides which are precursors to modified oligonucleotides which are useful as hybridization probes.

Simple synthesis of 4-thiothymidine, 4-thiouridine and 6-thio-2′-deoxyguanosine

Xu, Yao-Zhong,Zheng, Qinguo,Swann, Peter F.

, p. 2817 - 2820 (2007/10/02)

4-triazolo-pyrimidine nucleosides and 6-O-(mesitylenesulfonyl)-2′-deoxyguanosine, when treated with thiolacetic acid at room temperature, gave the corresponding 4-thiopyrimidine nucleosides and 6-thio-2′-deoxyguanosine with high yields (86-93%). Possible mechanisms are discussed.

A convenient synthesis of 2'-deoxy-6-thioguanosine, ara-guanine, ara-6-thioguanine and certain related purine nucleosides by the stereospecific sodium salt glycosylation procedure [1]

Hanna,Ramasamy,Robins,Revankar

, p. 1899 - 1903 (2007/10/02)

A simple and high-yield synthesis of biologically significant 2'-deoxy-6-thioguanosine, ara-6-thioguanine and araG has been accomplished employing the stereospecific sodium salt glycosylation method. Glycosylation of the sodium salt of 6-chloro- and 2-amino-6-chloropurine (1 and 2, respectively) with 1-chloro-2-deoxy-3,5-di-O-(p-toluoyl)-α-D-erythro-pentofuranose gave the corresponding N-9 substituted nucleosides as major products with the β-anomeric configuration (4 and 5, respectively) along with a minor amount of the N-7 positional isomers (6 and 7). Treatment of 4 with hydrogen sulfide in methanol containing sodium methoxide gave 2'-deoxy-6-thioinosine in 93% yield. Similarly, 5 was transformed into 2'-deoxy-6-thioguanosine (β-TGdR, 11) in 71% yield. Reaction of the sodium salt of 2 with 1-chloro-2,3,5-tri-O-benzyl-α-D-arabinofuranose gave N-7 and N-9 glycosylated products 13 and 9, respectively. Debenzylation of 9 with boron trichloride at -78° gave the versatile intermediate 2-amino-6-chloro-9-β-D-arabinofuranosylpurine 62% yield. Direct treatment of 14 with sodium hydrosulfide furnished ara-6-thioguanine. Alkaline hydrolysis of 14 readily gave 9-β-D-arabinofuranosylguanine (araG, 17), which on subsequent phosphorylation with phosphorus oxychloride in trimethyl phosphate afforded araG 5'-monophosphate.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 789-61-7